Loomis, Sayles & Company’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-316,327
Closed -$20M 1170
2015
Q4
$20M Sell
316,327
-1,449
-0.5% -$98.7K 0.06% 282
2015
Q3
$20.8M Sell
317,776
-47,632
-13% -$3.16M 0.06% 274
2015
Q2
$24.7M Buy
365,408
+54,971
+18% +$3.03M 0.07% 260
2015
Q1
$13.3M Buy
+310,437
New +$13.8M 0.04% 438
2014
Q2
Sell
-470,583
Closed -$26.2M 796
2014
Q1
$26.2M Sell
470,583
-3,207
-0.7% -$185K 0.07% 256
2013
Q4
$22.8M Sell
473,790
-4,520
-0.9% -$190K 0.07% 303
2013
Q3
$20.1M Sell
478,310
-2,600
-0.5% -$124K 0.07% 322
2013
Q2
$21.7K Buy
+480,910
New +$18.9M 0.08% 269

Other funds holding IMPV

Loomis, Sayles & Company's IMPV Position: Q1 2016 in Review

Loomis, Sayles & Company sold out of Imperva, Inc. (IMPV) in Q1 2016, closing a stake of 316,327 shares — an estimated $20M sold.

Loomis, Sayles & Company first reported a position in IMPV in Q2 2013 and held it in 8 quarters. The position peaked at $26.2M in Q1 2014. 160 funds tracked by Wall St. Rank hold IMPV as of Q1 2016.

  • Loomis, Sayles & Company reported no remaining Imperva, Inc. position as of Q1 2016 after selling out during the quarter.
  • Loomis, Sayles & Company sold 316,327 Imperva, Inc. shares in Q1 2016, an estimated $20M.
  • Loomis, Sayles & Company first reported a position in Imperva, Inc. in Q2 2013 and held it in 8 quarters.
  • Loomis, Sayles & Company's Imperva, Inc. position peaked at $26.2M in Q1 2014.
  • 160 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2016.

Based on Loomis, Sayles & Company's 13F filing for Q1 2016, filed 13 May 2016.